Global Market and Policy Landscape
The TB diagnostics market in 2026 is driven by large-scale government procurement and international funding (Global Fund, USAID).
WHO Consolidated Guidelines: The 2026 WHO guidelines mandate that all persons suspected of having TB should receive an mWRD as their initial diagnostic test, rather than traditional microscopy.
Private-Sector Engagement: New "Social Impact Bonds" are being used to subsidize the cost of high-tech molecular tests in private pharmacies and clinics, ensuring that a patient's socioeconomic status does not dictate the quality of their diagnosis.
1 View

